MeiraGTx Holdings PLC
$ 11.32
8.74%
18 Jun - close price
- Market Cap 1,048,340,000 USD
- Current Price $ 11.32
- High / Low $ 11.74 / 10.61
- Stock P/E N/A
- Book Value -0.71
- EPS -1.48
- Next Earning Report 2026-08-13
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.28 %
- ROE -3.68 %
- 52 Week High 11.85
- 52 Week Low 6.07
About
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York.
Analyst Target Price
$28.25
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-14 | 2026-03-12 | 2025-11-13 | 2025-08-14 | 2025-05-07 | 2025-03-12 | 2024-11-12 | 2024-08-12 | 2024-05-09 | 2024-03-14 | 2023-11-14 | 2023-08-10 |
| Reported EPS | -0.57 | 0.19 | -0.62 | -0.48 | -0.51 | -0.5 | -0.55 | -0.76 | -0.32 | -0.42 | -0.74 | -0.53 |
| Estimated EPS | -0.4475 | -0.564 | -0.5 | -0.4733 | -0.5 | -0.56 | -0.52 | -0.4 | -0.5 | -0.11 | -0.55 | -0.57 |
| Surprise | -0.1225 | 0.754 | -0.12 | -0.0067 | -0.01 | 0.06 | -0.03 | -0.36 | 0.18 | -0.31 | -0.19 | 0.04 |
| Surprise Percentage | -27.3743% | 133.6879% | -24% | -1.4156% | -2% | 10.7143% | -5.7692% | -90% | 36% | -281.8182% | -34.5455% | 7.0175% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-13 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.39 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MGTX
2026-06-18 22:09:44
MeiraGTx Holdings PLC (MGTX) has an institutional shareholding score of 5.00, placing it 133rd out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 59.59%, a 4.66% decrease quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, with 62.13K shares, despite an 84.48% decrease in holdings.
2026-06-18 11:39:56
MeiraGTx Holdings PLC (MGTX) has an earnings forecast score of 8.50, ranking 108 out of 388 in its industry. Analysts have set an average price target of $27.00, with a high of $50.00 and a low of $15.00, predominantly recommending a "Buy" for the stock. The company's expected revenue for the next quarter is $15.66 million, and its EPS for the next quarter is projected at $-0.41.
2026-06-18 09:39:56
MeiraGTx Holdings PLC (MGTX) has a current valuation score of 9.46, placing it 32nd out of 388 companies in the Biotechnology & Medical Research industry. Its P/E ratio is -7.02, which is significantly below its recent high but slightly above its recent low. Key valuation metrics like P/B, P/S, and P/CF data have not yet been disclosed by the company.
2026-06-18 00:39:18
This article provides a detailed historical overview of dividends and stock splits for MeiraGTx Holdings PLC (MGTX). It notes that no dividends have been distributed in the past five years and no stock split data is available. The page also presents current stock performance data and an overview of market information for MGTX.
2026-06-18 00:39:18
This article provides a revenue breakdown for MeiraGTx Holdings PLC (MGTX), although it states that the relevant data for business segments, regional revenue, and profit contribution has not yet been disclosed by the company. It briefly shows the stock's current trading price and market capitalization. The article is hosted on TradingKey, a platform offering financial news, analysis, and tools.
2026-06-16 09:09:56
MeiraGTx Holdings plc Director Neil Mendoza was granted 66,641 Restricted Share Units (RSUs) on June 11, 2026. These RSUs will convert into ordinary shares upon settlement and are set to vest on the earlier of June 11, 2027, or the day before the company's 2027 annual shareholders' meeting. Mendoza has chosen for the RSUs to become settleable after he ceases to be a director, bringing his total reported RSU holdings to 66,641 units post-grant.
